Gil Beyen
Director/Board Member bij PHAXIAM THERAPEUTICS S.A.
Vermogen: 1 558 $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Denis Dufrane | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | 11 jaar |
Eric Soyer | M | 57 | 1 jaar | |
Dirk Reyn | M | 62 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | 6 jaar |
Marleen Johanna Limbourg | M | - |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | 10 jaar |
Philippe Archinard | M | 63 | 1 jaar | |
Robert Sebbag | M | 73 | 1 jaar | |
Philippe Durieux | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Eric Jean Marie Leire | M | 66 | 1 jaar | |
Martine George | M | 76 | 1 jaar | |
Virginie Cartage | F | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Bart Jan Victor Goedseels | M | 57 |
Waterleau NV
Waterleau NV Water UtilitiesUtilities Waterleau NV engages in the provision of water technology services. It offers solutions for water, wastewater, air, and new energy. Its solutions are designed for managing the complete water cycle from process water and drinking water production, over wastewater treatment and discharge compliance to energy, water and nutrient recovery. The company was founded by Luc Vriens, Eddy Frans, Jean-Marie Ghislain, Willy Gils, Ron Gerards and Bernard Lemaitre in 2000 and is headquartered in Wespelaar, Belgium. | - |
Johan Cardoen | M | 65 |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.
Université Catholique de Louvain
| 4 jaar |
Hilde Windels | F | 59 | 1 jaar | |
Catherine Verfaillie | F | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Willem Beyen | M | - |
Axxis V&C BV
Axxis V&C BV Miscellaneous Commercial ServicesCommercial Services Axxis V & C BV is a Belgian company that provides business and management consulting services. The private company is based in Haasrode, Belgium. The company was founded in 1998 and the CEOs are Gil Beyen, Nadine Buyle, and Willem Beyen. | 6 jaar |
Andrew Abrams | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Leila Nicolas | F | - | 1 jaar | |
Anne-Cécile Fumey | F | - | 1 jaar | |
Cindy Fevre | M | - | 1 jaar | |
Nadine Buyle | F | - |
Axxis V&C BV
Axxis V&C BV Miscellaneous Commercial ServicesCommercial Services Axxis V & C BV is a Belgian company that provides business and management consulting services. The private company is based in Haasrode, Belgium. The company was founded in 1998 and the CEOs are Gil Beyen, Nadine Buyle, and Willem Beyen. | 18 jaar |
Christian Raftopoulos | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Frédérique Vieville | F | - | 1 jaar | |
Karine Charton | M | - | 1 jaar | |
Pascal Birman | M | - | 1 jaar | |
Cédric Sacré | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Johan Vanlauw | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Patrick van Beneden | M | 62 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | - |
Philippe Monteyne | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Johan Heylen | M | 56 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | - |
Jean-Pierre Bizet | M | 76 |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Jim van Heusden | M | 53 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | - |
Ruth Devenyns | F | 59 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | - |
Staf van Reet | M | - |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | 29 jaar |
Eric-Paul Pâques | M | 70 |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | 7 jaar |
Philippe Stas | M | - |
Belgian Association for Bioindustries
| - |
Wim Goemaere | M | - |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | 29 jaar |
Koen de Witte | M | - |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | - |
Jérôme Bailly | M | 45 | 1 jaar | |
Christina Franssen | M | - |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Herman Verrelst | M | 51 |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | - |
Céline Breda | F | 54 | 1 jaar | |
Didier Hoch | M | 68 | 1 jaar | |
Chris de Jonghe | M | - |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | - |
Thibaut du Fayet | M | 56 | 1 jaar | |
Koen Huygens | M | - | 23 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Willy W. Duron | M | 79 | - | |
Joseph Werne | M | - |
The University of Chicago
| 6 jaar |
Catherine Kleinmuntz | M | - |
The University of Chicago
| - |
Willem Broekaert | M | - |
Université Catholique de Louvain
| 4 jaar |
Armando J. Arrieta M. | M | - |
Université Catholique de Louvain
| 5 jaar |
Igal Litovsky | M | - |
The University of Chicago
| 4 jaar |
Mark Phelan | M | 55 |
The University of Chicago
| 3 jaar |
Federico L. Kaune | M | - |
The University of Chicago
| 4 jaar |
Frank Hazevoets | M | 57 | 6 jaar | |
Bill Bergman | M | - |
The University of Chicago
| 3 jaar |
Christine Morris | F | - |
Université Catholique de Louvain
| 6 jaar |
Frank P. Luyten | M | 69 | 11 jaar | |
Mark Nydam | M | - |
The University of Chicago
| 3 jaar |
Eduardo Bravo Fernández de Araoz | M | 58 | 13 jaar | |
Claudia D'Augusta | M | 54 | 7 jaar | |
Daniel J. Young | M | - |
The University of Chicago
| 4 jaar |
Baron Jean Stéphenne | M | 73 | - | |
Jeffrey D. Abbey | M | 61 |
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | - |
Richard C. Wirthlin | M | - |
The University of Chicago
| 3 jaar |
Sven Arne Andréasson | M | 72 | 2 jaar | |
Catherine Stehman-Breen | M | 61 |
The University of Chicago
| 3 jaar |
William C. Stern | M | 60 |
The University of Chicago
| 3 jaar |
Giorgio de Santis | M | - |
The University of Chicago
| 5 jaar |
An Moonen | F | - | 8 jaar | |
Stanley Ryan | M | 62 |
The University of Chicago
| 2 jaar |
Jeremy Feigelson | M | - |
The University of Chicago
| 3 jaar |
David Abramson | M | - |
The University of Chicago
| 2 jaar |
Russell Greig | M | 71 | 6 jaar | |
Roland Pirmez | M | 64 |
Université Catholique de Louvain
| 6 jaar |
Edward A. Receski | M | - |
The University of Chicago
| 3 jaar |
Phillipa White | F | - |
The University of Chicago
| 4 jaar |
Nithi Patarachoke | M | 62 |
The University of Chicago
| 2 jaar |
Byung-Do Kim | M | 65 |
The University of Chicago
| 4 jaar |
Charles A. Glass | M | - |
The University of Chicago
| 4 jaar |
Onaiza Cadoret-Manier | F | 60 |
The University of Chicago
| 2 jaar |
Samuel Mitchell | M | 63 |
The University of Chicago
| 2 jaar |
Jay T. Goodwin | M | - |
The University of Chicago
| 3 jaar |
Mike Bacevich | M | - |
The University of Chicago
| 2 jaar |
Frank D. Gordon | M | - |
The University of Chicago
| 2 jaar |
F. Stepan | M | 63 |
The University of Chicago
| 2 jaar |
Paul D. Scanlon | M | - |
The University of Chicago
| 2 jaar |
Jason B. Selch | M | 62 |
The University of Chicago
| 2 jaar |
James P. Gordon | M | - |
The University of Chicago
| 2 jaar |
Brian Charles Fargo | M | 79 |
The University of Chicago
| 2 jaar |
Claire Percarpio | F | - |
The University of Chicago
| 2 jaar |
Bonnie A. Barsamian | F | - |
The University of Chicago
| 3 jaar |
Joseph R. Eshoo | M | - |
The University of Chicago
| 2 jaar |
Kim Miller | M | - |
The University of Chicago
| 2 jaar |
Peter Burgi | M | - |
The University of Chicago
| 3 jaar |
Alan W. Bieler | M | - |
The University of Chicago
| 2 jaar |
James Snyder | M | 62 |
The University of Chicago
| 2 jaar |
John F. Haley | M | - |
The University of Chicago
| 4 jaar |
Guy Nohra | M | 63 |
The University of Chicago
| 2 jaar |
John Willmoth | M | - |
The University of Chicago
| 3 jaar |
David Kathman | M | - |
The University of Chicago
| 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
België | 43 | 43.00% |
Verenigde Staten | 41 | 41.00% |
Frankrijk | 16 | 16.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties